Tweedy Browne Co. - Tweedy Browne Value Fund
Holding/activity history for Novartis AG (NVS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 50,749 | 1.36 | $115.17 | ||
| 2024 Q2 | 50,749 | 1.28 | $106.45 | ||
| 2024 Q1 | 50,749 | 1.12 | $97.01 | ||
| 2023 Q4 | 50,749 | 1.23 | $100.83 | ||
| 2023 Q3 | 50,749 | 1.36 | $102.19 | ||
| 2023 Q2 | 50,749 | 1.23 | $100.59 | ||
| 2023 Q1 | 50,749 | 1.14 | $91.96 | ||
| 2022 Q4 | 50,749 | 1.20 | $90.45 | ||
| 2022 Q3 | 50,749 | 1.13 | $76.44 | ||
| 2022 Q2 | 50,749 | 1.13 | $84.45 | ||
| 2022 Q1 | 50,749 | 1.07 | $88.16 | ||
| 2021 Q4 | 50,749 | 1.08 | $88.10 | ||
| 2021 Q3 | 50,749 | 1.02 | Reduce 43.43% | 0.78 | $81.91 |
| 2021 Q2 | 89,704 | 1.93 | $91.22 | ||
| 2021 Q1 | 89,704 | 1.90 | Reduce 12.22% | 0.26 | $85.82 |
| 2020 Q4 | 102,189 | 2.44 | $94.31 | ||
| 2020 Q3 | 102,189 | 2.61 | Reduce 28.87% | 1.06 | $86.98 |
| 2020 Q2 | 143,657 | 3.69 | $87.11 | ||
| 2020 Q1 | 143,657 | 3.82 | $82.07 | ||
| 2019 Q4 | 143,657 | 3.38 | $94.91 | ||
| 2019 Q3 | 143,657 | 3.13 | $86.79 | ||
| 2019 Q2 | 143,657 | 3.15 | $91.49 | ||
| 2019 Q1 | 143,657 | 3.32 | Reduce 9.86% | 0.36 | $96.17 |
| 2018 Q4 | 159,377 | 3.46 | Reduce 19.41% | 0.83 | $85.25 |
| 2018 Q3 | 197,762 | 3.75 | Reduce 13.51% | 0.59 | $86.41 |
| 2018 Q2 | 228,655 | 3.55 | $75.81 | ||
| 2018 Q1 | 228,655 | 3.75 | $80.68 | ||
| 2017 Q4 | 228,655 | 3.84 | Reduce 10.11% | 0.43 | $84.56 |
| 2017 Q3 | 254,363 | 4.06 | $85.68 | ||
| 2017 Q2 | 254,363 | 4.18 | $83.33 | ||
| 2017 Q1 | 254,363 | 3.87 | $74.28 | ||
| 2016 Q4 | 254,363 | 4.03 | $72.91 | ||
| 2016 Q3 | 254,363 | 4.25 | $78.81 | ||
| 2016 Q2 | 254,363 | 4.45 | $82.27 | ||
| 2016 Q1 | 254,363 | 3.98 | $72.78 | ||
| 2015 Q4 | 254,363 | 4.49 | Reduce 13.53% | 0.70 | $86.71 |
| 2015 Q3 | 294,148 | 5.58 | Reduce 3.41% | 0.20 | $91.49 |
| 2015 Q2 | 304,545 | 5.67 | $98.60 | ||
| 2015 Q1 | 304,545 | 5.74 | $98.99 | ||
| 2014 Q4 | 304,545 | 5.39 | $92.94 | ||
| 2014 Q3 | 304,545 | 5.19 | $94.35 | ||
| 2014 Q2 | 304,545 | 4.67 | $90.55 | ||
| 2014 Q1 | 304,545 | 4.69 | $84.90 | ||
| 2013 Q4 | 304,545 | 4.35 | $80.06 | ||
| 2013 Q3 | 304,545 | 4.29 | $76.86 | ||
| 2013 Q2 | 304,545 | 4.19 | $70.92 | ||
| 2013 Q1 | 304,545 | 4.15 | $71.23 | ||
| 2012 Q4 | 304,545 | 4.00 | $62.76 | ||
| 2012 Q3 | 304,545 | 4.21 | $61.24 | ||
| 2012 Q2 | 304,545 | 4.08 | $55.89 | ||
| 2012 Q1 | 304,545 | 3.92 | Add 14.02% | 0.48 | $55.28 |
| 2011 Q4 | 267,100 | 3.96 | Add 18.71% | 0.62 | $57.43 |
| 2011 Q3 | 225,000 | 3.51 | $55.93 | ||
| 2011 Q2 | 225,000 | 3.22 | $61.16 | ||
| 2011 Q1 | 225,000 | 2.81 | Add 11.80% | 0.30 | $54.46 |
| 2010 Q4 | 201,255 | 3.02 | $58.96 | ||
| 2010 Q3 | 201,255 | 3.17 | $57.68 | ||
| 2010 Q2 | 201,255 | 3.12 | $48.78 | ||
| 2010 Q1 | 201,255 | 2.98 | $54.11 | ||
| 2009 Q4 | 201,255 | 3.00 | $54.66 | ||
| 2009 Q3 | 201,255 | 2.93 | Add 65.64% | 1.16 | $49.97 |
| 2009 Q2 | 121,500 | 1.58 | $40.49 | ||
| 2009 Q1 | 121,500 | 1.79 | Buy | 1.79 | $37.88 |